Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT05158023. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Trial to Evaluate the Efficacy and Safety of ASLAN004 in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase 2b study designed to evaluate the efficacy and safety of ASLAN004 in adult patients with moderate-to-severe Atopic Dermatitis (AD) who are candidates for systemic therapy. This study will have 5 treatment arms (4 active and 1 placebo).
Study identification
- NCT ID
- NCT05158023
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 302 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 16, 2022 (Actual)
- Primary completion
- Jun 13, 2023 (Actual)
- Completion
- Sep 5, 2023 (Actual)
- Last update posted
- Apr 26, 2024
2022 – 2023
United States locations
- U.S. sites
- 47
- U.S. states
- 20
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ASLAN Investigative Site | Birmingham | Alabama | 35209 | — |
| ASLAN Investigative Site | Birmingham | Alabama | 35244 | — |
| ASLAN Investigative Site | Little Rock | Arkansas | 72205 | — |
| Tooraj Raoof, MD | Encino | California | 91436 | — |
| ASLAN Investigative Site | Fountain Valley | California | 92708 | — |
| Center for Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| ASLAN Investigative Site | Los Angeles | California | 90033 | — |
| ASLAN Investigative Site | Los Angeles | California | 90057 | — |
| MedDerm Associates | San Diego | California | 92103 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Skin Care Research, LLC | Boca Raton | Florida | 33486 | — |
| Encore Medical Research of Boynton Beach | Boynton Beach | Florida | 33436 | — |
| Driven Research, LLC | Coral Gables | Florida | 33134 | — |
| Aby's New Generation Research, Inc. | Hialeah | Florida | 33016 | — |
| ASLAN Investigative Site | Hollywood | Florida | 33021 | — |
| Skin Research of South Florida | Miami | Florida | 33173 | — |
| ASLAN Investigative Site | Miami | Florida | 33176 | — |
| ASLAN Investigative Site | North Miami Beach | Florida | 33162 | — |
| ASLAN Investigative Site | Saint Augustine | Florida | 32080 | — |
| ASLAN Investigative Site | Tampa | Florida | 33607 | — |
| ForCare Clinical Research | Tampa | Florida | 33613 | — |
| ASLAN Investigative Site | Columbus | Georgia | 31904 | — |
| Skin Care Physicians of Georgia | Macon | Georgia | 31217 | — |
| ASLAN Investigative Site | Meridian | Idaho | 83642 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | — |
| ASLAN Investigative Site | Louisville | Kentucky | 40217 | — |
| ASLAN Investigative Site | Baton Rouge | Louisiana | 70808 | — |
| Allcutis Research LLC | Beverly | Massachusetts | 01915 | — |
| ASLAN Investigative Site | Quincy | Massachusetts | 02169 | — |
| ASLAN Investigative Site | Ann Arbor | Michigan | 48103 | — |
| ASLAN Investigative Site | Las Vegas | Nevada | 89148 | — |
| Forest Hills Dermatology Group | Kew Gardens | New York | 11415 | — |
| Bobby Buka MD, PC | New York | New York | 10012 | — |
| ASLAN Investigative Site | New York | New York | 10075 | — |
| ASLAN Investigative Site | Medford | Oregon | 97504 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Clinical Partners, LLC | Johnston | Rhode Island | 02919 | — |
| Clinical Research Center of the Carolinas | Charleston | South Carolina | 29407 | — |
| ASLAN Investigative Sites | Rapid City | South Dakota | 57702 | — |
| ASLAN Investigative Site | Nashville | Tennessee | 37215 | — |
| Dermatology Treatment and Research Center | Dallas | Texas | 75230 | — |
| Modern Research Associates | Dallas | Texas | 75231 | — |
| Menter Dermatology Research Institute | Dallas | Texas | 75246 | — |
| Center for Clinical Studies LTD, LLP | Houston | Texas | 77004 | — |
| ASLAN Investigative Site | San Antonio | Texas | 78209 | — |
| ASLAN Investigative Site | South Jordan | Utah | 84095 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05158023, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 26, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05158023 live on ClinicalTrials.gov.